Aurinia Pharmaceuticals Inc. — Form SCHEDULE 13D/A
Filed August 26, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
Seven individuals associated with South Korea's ILJIN Steel and ILJIN SNT (listed as reporting persons) filed a Schedule 13D/A amendment regarding their holdings in Aurinia Pharmaceuticals. The filing identifies the reporting persons' names, citizenship (South Korea), occupations (business persons), and shared business address (ILJIN Building, Seoul). Specific share counts, ownership percentages, transaction dates, and dollar amounts are NOT disclosed in this exhibit extract.
Why this rating
Administrative amendment filing; no transaction amounts, share counts, or material changes disclosed in excerpt. ILJIN's prior stake in $1B company unclear from this document alone.
See more from August 26, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.